This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health professional risk communication

Amplatzer Septal Occluder - Risk of Erosion - For the Public

Starting date:
April 14, 2014
Posting date:
April 14, 2014
Type of communication:
Public Communication
Subcategory:
Medical Device
Source of recall:
Health Canada
Issue:
Important Safety Information
Audience:
General Public
Identification number:
RA-38939

This is duplicated text of a letter from St. Jude Medical Canada, Inc. Contact the company for a copy of any references, attachments or enclosures.

Notice about Health Canada advisories

PUBLIC COMMUNICATION - Health Canada Endorsed Important Safety Information on Amplatzer Septal Occluder

April 14, 2014

Subject: Risk of Erosion associated with the Amplatzer Septal Occluder (ASO)

St. Jude Medical Inc., in collaboration with Health Canada, has issued a Health Professional Communication regarding a rare but serious risk of erosion associated with the AMPLATZER Septal Occluder (ASO). The ASO is a medical device implant that is used in adults and children to close an opening (hole) in the wall (also known as septum) of the heart.

St. Jude Medical has updated the label for the ASO with respect to the adverse event of erosion.

  • Erosion is a rare but potential life threatening event which may be caused by the ASO rubbing against the wall of the heart or surrounding structures.
  • Symptoms of possible erosion may include shortness of breath, chest pain, fainting, and/or rapid or irregular heart beat.
  • Any patient with an ASO who experiences any of the symptoms of erosion should immediately call his or her heart specialist, or go to the nearest emergency room.

Managing marketed health product-related adverse incidents depends on health care professionals and consumers reporting them. Any case of erosion or other serious or unexpected adverse incidents with an ASO should be reported to St. Jude Medical or Health Canada at the following addresses:

St. Jude Medical Canada, Inc.
2100 Derry Rd. West, Suite 400
Mississauga, ON L5N 0B3
Telephone: 1-888-276-4170
Fax: 1-877-800-7562

Any suspected adverse incident can also be reported to:
Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 2003D
Ottawa, Ontario K1A 0K9
Telephone: The Inspectorate Hotline 1-800-267-9675

The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada Web site.

For other medical device inquiries related to this communication, please contact Health Canada at:
Marketed Health Products Directorate
E-mail: mhpd_dpsc.public@hc-sc.gc.ca
Telephone: 613-954-6522
Fax: 613-952-7738

A copy of this communication is available at http://professional-intl.sjm.com/resources/product-performance/amplatzer-septal-occluder-performance/canadian-updates and on the Health Canada Website. Information for patients can also be found at www.atrialseptaldefectanswers.com.

Patients should address any health-related concerns directly with their physician. Patients with an ASO who have health-related concerns regarding their implanted device should address their concerns directly with their heart specialist. For other questions, please contact St. Jude Medical Canada Inc. at the address or telephone number listed above.

original signed by

Frank Shannon
Director, Regulatory Affairs and Quality Systems
St. Jude Medical Canada, Inc.